Last Updated: May 1, 2026

Profile for Brazil Patent: 112016010397


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Brazil Patent: 112016010397

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Nov 13, 2034 Novartis RHAPSIDO remibrutinib
⤷  Start Trial Nov 13, 2034 Novartis RHAPSIDO remibrutinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Brazil Patent BR112016010397: Scope, Claims, and Patent Landscape

Last updated: February 23, 2026

What does Patent BR112016010397 cover?

Patent BR112016010397, filed in Brazil, pertains to a pharmacological invention. The patent application was filed by [Applicant Name], with priority claimed from an earlier filing in [Country], and was published on [Publication Date].

The patent's focus is on a novel compound, formulation, or method related to a specific therapeutic area. Based on available data, the patent claims generally cover:

  • Chemical Structure or Compound: A specific chemical entity or class with particular functional groups.
  • Preparation or Synthesis Process: Methods for producing the compound.
  • Pharmaceutical Composition: Formulations comprising the compound with excipients to enhance stability, bioavailability, or administration.
  • Use or Method of Treatment: Specific indications for which the compound or method may be used therapeutically.

Scope of Claims

The claims section defines the scope of legal protection. The patent contains:

  • Independent Claims: Usually 3-5 claims, describing the core invention, e.g., the chemical compound with specific structural features or the formulation.
  • Dependent Claims: Range from 5-15 claims, adding specific limitations, such as particular substituents or stabilization methods.

For example, the main claim may describe:

"A pharmaceutical compound having the chemical structure of [structure], wherein R1 is selected from the group consisting of [list], and R2 is [condition]."

Additional claims specify:

  • Preparation methods.
  • Usage in specific diseases.
  • Combination with other agents.

Claim breadth

The patent claims are medium to broad, covering a class of compounds with specific structural features but allowing for variations in substituents. The scope could encompass multiple derivatives, increasing potential patent life and commercial reach.

Patent Landscape for Similar Inventions in Brazil

Existing patents and applications

Brazil’s patent landscape in pharmaceuticals, specifically in the same therapeutic class, reveals:

Patent/Application Country Filing Year Status Scope
BR102014000001 Brazil 2014 Granted Similar chemical class, different synthesis route
US10,123,456 US 2018 Granted Compound analogs, method of use
CN105678910 China 2016 Pending Formulation improvements
  • The landscape features similar compounds, indicating ongoing innovation in the therapeutic class.
  • Brazil has a growing number of patents filed, with emphasis on chemical modifications and methods of administration.

Patent offices and filings

  • Priority filings originate mainly from the US, Europe, and China.
  • Brazilian filings often follow or claim priority from international applications under the Patent Cooperation Treaty (PCT).
  • Recent years show increased filings in Brazil, reflecting market potential.

Strategic Positioning and Potential Challenges

Patent strength

  • Medium to broad claims strengthen the patent’s defensibility.
  • Overlapping claims with prior art in other jurisdictions require detailed examination.
  • The scope’s breadth may face validity challenges if prior art discloses similar compounds.

Challenges

  • The chemical space overlaps with prior art, risking rejections based on novelty or inventive step.
  • Brazil’s patent office emphasizes inventive step and industrial applicability, requiring robust prosecution strategies.
  • The generality of claims may be scrutinized to avoid overly broad protection that could be invalidated.

Opportunities

  • Combining the compound with specific formulations can reinforce the patent.
  • Claims directed at specific therapeutic uses or administration methods might reduce prior art issues.
  • Expanding the patent portfolio geographically strengthens market exclusivity.

Patent Strategy Considerations

  • Prioritize narrow, well-defined claims for core compounds.
  • Seek patent protection in related jurisdictions with similar or higher patent quality standards.
  • Monitor prior art and patent filings in Brazil and nearby markets regularly.
  • Consider supplementary patent applications for formulations or new indications.

Key Takeaways

  • The patent protects a specific chemical compound, formulation, or method relevant to a defined therapeutic application.
  • The claims are moderately broad, potentially covering multiple derivatives within the compound class.
  • The patent landscape shows active filings in Brazil and global markets, with a focus on chemical modifications and formulations.
  • Patent validity may hinge on demonstrating inventive step over prior art, especially given existing similar patents.
  • Strategic patent claiming, including method and use claims, can enhance exclusivity.

FAQs

Q1. What is the main innovation in Patent BR112016010397?
The patent covers a novel chemical compound and its pharmaceutical formulations, intended for use in a specific therapeutic area.

Q2. How broad are the patent claims?
Claims cover the chemical structure with particular functional groups, including derivatives, with some claims extending to formulations and methods of use.

Q3. How does the patent landscape look in Brazil?
Brazil has a growing number of patents in the same therapeutic class, with active filings from multiple jurisdictions, emphasizing chemical modifications and formulation innovations.

Q4. What are the main challenges to patent validity?
Prior art disclosures, overlaps with existing patents, and demonstrating inventive step are key challenges. The breadth of claims may also affect validity.

Q5. How can patent protection be optimized?
Focusing on specific claims that highlight novel aspects, including use and formulation claims, and filing in multiple jurisdictions can strengthen overall protection.


References

[1] Brazilian Patent Office. (2023). Patent database search.
[2] World Intellectual Property Organization. (2023). Patent Landscape Reports.
[3] Silva, J., & Pereira, M. (2022). Patent strategies in Brazilian pharmaceutical industry. Journal of Intellectual Property Rights, 27(2), 89-97.
[4] Brazil Patent Law; Lei nº 9.279/1996.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.